1/68
Looks like no tags are added yet.
Treatment for Asthma and COPD: Bronchodilators NTN
Beta-2 Adrenergic Agonists
Methylxanthines
Anticholinergics
Treatment for Asthma and COPD: Anti-inflammatory Drugs NTN
Glucocorticoids (Steroids)
Leukotriene
Cromolyn
Asthma:
A chronic allergic disorder characterized by episodes of severe breathing difficulty, coughing, and wheezing.
COPD:
Chronic Obstructive Pulmonary Disease, a lung disease commonly seen in smokers
- Worsens over time
- Irreversible
Bronchodilators: Beta-2 Adrenergic Agonists MOA
Activates Beta-2 receptors in the lung, causing bronchoDILATION
Bronchodilators: Beta-2 Adrenergic Agonists: Possible Systemic Effects
Systemic effects of Beta-2 Agonists:
Tachycardia (most common)
Dysrythmias
Angina
Tremor (Rare)
Seizures (Rare)
Short-Acting Beta-2 Agonists (SABA)
Albuterol (ProAir)
Levalbuterol (Xopenex)
Short-Acting Beta-2 Agonists (SABA) Therapeutic effects
Inhaled with quick onset of action
- Used PRN to abort an acute asthma attack
- Goal: use twice a week or less
- Higher use = asthma not well controlled = additional medications
Short-Acting Beta-2 Agonists (SABA) Dosage
Metered-Dose Inhaler (MDI)
Dry Powder Inhaler
Nebulizer
Short-Acting Beta-2 Agonists (SABA) Administration Technique
2 Breaths: wait 1 minute between each breath.
- Bronchodilation occurs and allows the second inhalation to penetrate deeply
Short-Acting Beta-2 Agonists (SABA) Administration Technique (MDI)
Use a spacer to increase medication delivery and prevent most of the dose from landing on the tongue
Short-Acting Beta-2 Agonists (SABA) Dosage Implications
Administer first when using other inhalers to allow maximum bronchodilation and absorption of all medications
Long-Acting Beta2-Agonist (LABAs)
Formoterol - Inhaler
Salmeterol (Serverent Diskus)- Inhaler
Terbutaline (oral)
Long-Acting Beta2-Agonist (LABAs) Administration
Taken on a fixed schedule or for long-term control
(q12h for inhalers)
- Used for Maintenance
Long-Acting Beta2-Agonist (LABAs): COPD
LABAs are preferred for patients with stable COPD
Long-Acting Beta2-Agonist (LABAs): Asthma
LABAs are always combined with glucocorticoids for patients with asthma
- Increased risk of DEATH when used alone
- FDA recommends combined inhalers
Bronchodilators: Methylxanthines
Theophyline
Bronchodilators: Methylxanthines (Theophylline) MOA
Relaxes bronchial smooth muscle
Bronchodilators: Methylxanthines (Theophylline) Therapeutic Effects
Maintenance of stable asthma
Long duration of action: good for patients with nocturnal asthma attacks
Bronchodilators: Methylxanthines (Theophylline) Toxicity S/S
N/V/D
Restlessness, Insomnia
Dysrythmias
Convulsions
Bronchodilators: Methylxanthines (Theophylline) Contraindications
DO NOT CONSUME CAFFEINE
Both are methylxanthines and can increase the risk of toxicity
Bronchodilators: Anticholinergics
Ipratropium (Atrovent) = Atropine Derivative
Tiotropoium (Spiriva)
Bronchodilators: Anticholinergics MOA
Blocks muscarinic receptors in the bronchi, reducing bronchoconstriction
Bronchodilators: Anticholinergics Pharmacokinetics
Only Available in Inhalants:
Long-acting and short-acting
Bronchodilators: Anticholinergics Adverse Effects
Few systemic effects, but clients may
develop anticholinergic effects
• Most common: Xerostomia (Dry mouth)
Glucocorticoids MOA
Decreases inflammatory mediators and infiltration with inflammatory cells
• Reduces mucus production and edema of airway mucosa
Inhaled Glucocorticoids:
Beclomethasone
Fluticasone (Flovent)
Oral/IV Glucocorticoids:
Prednisone,
Methylprednisolone
Cortisone
Inhaled Glucocorticoids: Pharmacokinetics
Take daily on a fixed schedule for long-term (chronic) management of COPD/Asthma
Inhaled Glucocorticoids: Adverse Effects
Growth suppression in children
Candidiasis (thrush) on the tongue, hoarseness; must rinse mouth/throat after use
Inhaled Glucocorticoids vs PO/IV
Acts locally with fewer systemic effects than PO/IV glucocorticoids: lower risk of hyperglycemia, immunosuppression, GI Bleed, or adrenal insufficiency
Leukotriene Modifiers
Montelukast (Singulair)
Leukotriene Modifiers: Montelukast (Singulair) MOA
Leukotriene receptor blocker- blocks activation of inflammatory leukotrienes
Leukotriene Modifiers: Montelukast (Singulair) Therapeutic Effects
Used to prevent exercise-induced bronchospasm (EIB)
- Administered on a fixed schedule
Leukotriene Modifiers: Montelukast (Singulair) Adverse Effects
Associated with neuropsychiatric events such as mood changes and suicidality (rare)
Cromolyn MOA
Reduces inflammation by stabilizing the cell membrane of mast cells,
reducing histamine and other inflammatory mediators
inhibiting eosinophils and other inflammatory cells
Cromolyn Implications
Less effective than other medications like glucocorticoids
- Third-Line Therapy
Cromolyn Pharmacokinetics
Administered via nebulizer
• Safest asthma medication
Medications used for Cough, Cold, Allergy:
Glucocorticoids: intranasal
Antihistamines
Sympathomimetics
Antitussives
Expectorants and Mucolytics
Histamine: Role in the Body
- Stored in secretory vesicles
- Release is triggered by activated antibodies or other substances
Histamine: Role of Antibodies
- Antibodies are activated by reexposure to allergens
-- First exposure creates antibodies; subsequent exposure activates the antibodies
- Other triggering substances require no prior exposure
Histamine: H1 Physiologic Response
Vasodilation: warmth, flushing, decreased blood
Increased capillary permeability: edema, decreased blood pressure
Bronchoconstriction
Mucus Production
Pain. ithcing
CNS effects: regulation of processes such as sleep-wake cycle, seizure suppression, cognition, and neurotransmitter release
Histamine: H2 Receptors Physiologic Response
Gastric Acid Secretion
Antihistamines: First-Generation H1 Antagonists MOA
Block histamine receptors and some block muscarinic receptors
Antihistamines: First-Generation H1 Antagonists
Diphenhydramine (Benadryl)
Hydroxyzine (Vistaril)
Promethazine (Phenergan)
Antihistamines: First-Generation H1 Pharmacodynamics
Lipid soluble with affinity for CNS histamine receptors = crosses BBB
Antihistamines: First-Generation H1 Antagonists Contraindications
Do NOT consume:
- Alcohol
- Additional anticholinergic drugs
Do NOT Operate:
- Heavy machinery/ or driving
Antihistamines: First-Generation H1 Antagonists Adverse Effects
Sedation
Anticholinergic Effects:
• Dry mucous membranes
• Urinary retention
• Constipation
Antihistamines: First-Generation H1 Antagonists Side Effects
Reduced:
flushing
Edema
Itching
Mucus production
Antihistamines: First-Generation H1 Antagonists Therapeutic vs Toxic Dose
CNS depression/drowsiness at therapeutic doses
CNS excitation at toxic doses; PARADOXICAL EFFECT in children and older adults
Antihistamines: First-Generation H1 Antagonists Adverse Effects (Promethazine (Phenergan) Extravasation
Extensive tissue damage
• IM preferred route
• IV: dilute to 25mg/mL over 1 minute
Antihistamines: Second Generation
Cetirizine (Zyrtec)
Fexofenadine (Allegra)
Loratadine (Claritin)
Antihistamines: Second Generation vs First Generation
Low lipid solubility and low affinity for CNS H1 receptors = does not easily cross the BBB
- Not sedating
- Antihistamine effects treat allergy symptoms without CNS or anticholinergic effects
Decongestants
Pseudoephedrine (Sudafed), Phenylephrine
Decongestants MOA
Activation of Alpha-1 receptors in the nose causes vasoconstriction, relieving congestion
Decongestants Adverse Effects
Rebound congestion when wears off
CNS stimulation (insomnia, irritability, anxiety)
Decongestants Adverse Effects Contraindications
Systemic vasoconstriction: hypertension (contraindications)
Decongestants Adverse Effects: Abuse potential
Abuse: pseudoephedrine can be made into methamphetamine
Antitussives: Opioid Cough Suppressants
Codiene
Antitussives: Non-Opioid Cough Suppressants (Dextromethorphan):
Dextromethorphan = Suppresses the cough reflex in the CNS
Antitussives: Non-Opioid Cough Suppressants (Benzonatate):
Benzonatate = Decreases sensitivity of
respiratory stretch receptors
Expectorants and Mucolytics: Expectorants MOA
Increase flow of respiratory secretions to allow for easier expulsion
Expectorants and Mucolytics: Expectorants
• Guaifenesin (Mucinex)
Expectorants and Mucolytics: Mucolytics MOA
Thin mucus
Expectorants and Mucolytics: Mucolytics
• Hypertonic saline
• Acetylcysteine (inhaled)
Which information should the nurse include when
teaching a patient about inhaled glucocorticoids?
A. Inhaled glucocorticoids have many significant adverse effects.
B. The principal side effects of inhaled
glucocorticoids include hypertension and weight gain.
C. Use of a spacer can minimize side effects.
D. Patients should rinse the mouth and gargle before administering inhaled glucocorticoids.
C. Use of a spacer can minimize side effects.
A patient is prescribed codeine as
an antitussive. Which symptom
will the nurse observe for as an
adverse effect of this medication?
A. Respiratory depression
B. Increased heart rate
C. Productive cough
D. Restlessness
A. Respiratory depression
Rationale: Codeine is an opioid, and its main adverse effect is RR Depression
A patient asks what medication would
be most effective in the treatment of
seasonal hay fever. The nurse will teach
the patient about the use of which
drug?
A. Azelastine [Astelin]
B. Chlorpheniramine [Chlor-Trimeton]
C. Fluticasone [Flonase]
D. Pseudoephedrine [Sudafed]
C. Fluticasone [Flonase]
Rationale: Steroid
A patient with asthma is prescribed albuterol [Proventil], 2 puffs 3 times a day. What should the nurse teach the patient to do?
A. Rinse the mouth after taking the prescribed dose.
B. Take an extra dose if breathing is
compromised.
C. Wait 1 minute between puffs from the
inhaler.
D. Take adequate amounts of calcium and vitamin D.
C. Wait 1 minute between puffs from the
inhaler.
Rationale: Leaving time between breaths allows for bronchodilation to occur and leads to better absorption of the drug